Reduced endothelial NO-cGMP vascular relaxation pathway during TNF-alpha-induced hypertension in pregnant rats.

Placental ischemia during pregnancy is thought to release cytokines such as tumor necrosis factor-alpha (TNF-alpha), which may contribute to the increased vascular resistance associated with pregnancy-induced hypertension. We have reported that a chronic twofold elevation in plasma TNF-alpha increases blood pressure in pregnant but not in virgin rats; however, the vascular mechanisms are unclear. We tested the hypothesis that increasing plasma TNF-alpha during pregnancy impairs endothelium-dependent vascular relaxation and enhances vascular reactivity. Active stress was measured in aortic strips of virgin and late-pregnant Sprague-Dawley rats untreated or infused with TNF-alpha (200 ng x kg(-1) x day(-1) for 5 days) to increase plasma level twofold. Phenylephrine (Phe) increased active stress to a maximum of 4.2 +/- 0.4 x 10(3) and 9.9 +/- 0.7 x 10(3) N/m2 in control pregnant and TNF-alpha-infused pregnant rats, respectively. Removal of the endothelium enhanced Phe-induced stress in control but not in TNF-alpha-infused pregnant rats. In endothelium-intact strips, ACh caused greater relaxation of Phe contraction in control than in TNF-alpha-infused pregnant rats. Basal and ACh-induced nitrite/nitrate production was less in TNF-alpha-infused than in control pregnant rats. Pretreatment of vascular strips with 100 microM N(G)-nitro-L-arginine methyl ester, to inhibit nitric oxide (NO) synthase, or 1 microM 1H-[1,2,4]oxadiazolo[4,3-]quinoxalin-1-one, to inhibit cGMP production in smooth muscle, inhibited ACh-induced relaxation and enhanced Phe-induced stress in control but not in TNF-alpha-infused pregnant rats. Phe contraction and ACh relaxation were not significantly different between control and TNF-alpha-infused virgin rats. Thus an endothelium-dependent NO-cGMP-mediated vascular relaxation pathway is inhibited in late-pregnant rats infused with TNF-alpha. The results support a role for TNF-alpha as one possible mediator of the increased vascular resistance associated with pregnancy-induced hypertension.

[1]  S. Abram,et al.  Reduced Uterine Perfusion Pressure During Pregnancy in the Rat Is Associated With Increases in Arterial Pressure and Changes in Renal Nitric Oxide , 2001, Hypertension.

[2]  J. Granger,et al.  Role of Endothelin B Receptors in Enhancing Endothelium-Dependent Nitric Oxide–Mediated Vascular Relaxation During High Salt Diet , 2001, Hypertension.

[3]  P. Huang,et al.  An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Granger,et al.  Stimulated mechanisms of Ca2+entry into vascular smooth muscle during NO synthesis inhibition in pregnant rats. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.

[5]  Paul M. Vanhoutte,et al.  Vascular biology: Old-timer makes a comeback , 1998, Nature.

[6]  K. Conrad,et al.  Circulating Levels of Immunoreactive Cytokines in Women with Preeclampsia , 1998, American journal of reproductive immunology.

[7]  J. Granger,et al.  Enhanced vascular reactivity during inhibition of nitric oxide synthesis in pregnant rats. , 1998, Hypertension.

[8]  J. Brien,et al.  The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-alpha]quinoxalin-1-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. , 1997, Canadian journal of physiology and pharmacology.

[9]  L. Ignarro,et al.  Evidence for the presence of an unusual nitric oxide- and citrulline-producing enzyme in rat kidney. , 1997, Biochemical and biophysical research communications.

[10]  K. Conrad,et al.  Placental Cytokines and the Pathogenesis of Preeclampsia , 1997, American journal of reproductive immunology.

[11]  R. Magness,et al.  Nitric oxide and pregnancy. , 1997, The American journal of physiology.

[12]  P. Vallance,et al.  Nitric oxide-mediated vasodilation in human pregnancy. , 1997, The American journal of physiology.

[13]  Chander P Arora,et al.  Long-term nitric oxide blockade in the pregnant rat: effects on blood pressure and plasma levels of endothelin-1. , 1996, American journal of obstetrics and gynecology.

[14]  G. Dekker,et al.  Nitric oxide, the endothelium, pregnancy and pre‐eclampsia , 1996, British journal of obstetrics and gynaecology.

[15]  B. Sibai,et al.  Preeclampsia and related disorders. Clinical aspects and relevance of endothelin and nitric oxide. , 1995, Clinics in perinatology.

[16]  G. Chaudhuri,et al.  The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat , 1995, British journal of pharmacology.

[17]  D. Kwiatkowski,et al.  Interleukin‐6, turnour necrosis factor and soluble turnour necrosis factor receptors in women with pre‐eclampsia , 1995 .

[18]  I. Greer,et al.  Increased concentrations of dytokines interleukin and interleukin‐1 receptor antagonist in plasma of women with preeclampsia: A mechanism for endothelial dysfunction? , 1994, Obstetrics and gynecology.

[19]  L. Peeters,et al.  Renal hemodynamics and volume homeostasis in pregnancy. , 1994, Obstetrical & gynecological survey.

[20]  M. Faas,et al.  A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. , 1994, American journal of obstetrics and gynecology.

[21]  Z. Ba,et al.  Administration of tumor necrosis factor-alpha in vivo depresses endothelium-dependent relaxation. , 1994, The American journal of physiology.

[22]  I. Charles,et al.  Induction of calcium-dependent nitric oxide synthases by sex hormones. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  A. Peaceman,et al.  Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. , 1994, American journal of obstetrics and gynecology.

[24]  M. Yoshizumi,et al.  Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. , 1993, Circulation research.

[25]  L. Rochelle,et al.  Identification of increased nitric oxide biosynthesis during pregnancy in rats , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  S. Davidge,et al.  Endogenous modulation of the blunted adrenergic response in resistance-sized mesenteric arteries from the pregnant rat. , 1992, American journal of obstetrics and gynecology.

[27]  M. Molnar,et al.  N omega-nitro-L-arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. , 1992, American journal of obstetrics and gynecology.

[28]  B. Brenner,et al.  Transcriptional regulation of the endothelin-1 gene by TNF-alpha. , 1992, The American journal of physiology.

[29]  R. Venuto,et al.  Increased peripheral resistance during reduced uterine perfusion pressure hypertension in pregnant rabbits. , 1992, The American journal of the medical sciences.

[30]  B. Sibai,et al.  Enhanced endothelium-derived relaxing factor activity in pregnant, spontaneously hypertensive rats. , 1991, American journal of obstetrics and gynecology.

[31]  A. Parent,et al.  Role of the endothelium in adrenergic responses of mesenteric artery rings of pregnant rats. , 1990, American journal of obstetrics and gynecology.

[32]  R. Cotran,et al.  Cytokines and endothelial cell biology. , 1990, Physiological reviews.

[33]  K. Conrad,et al.  Plasma level, urinary excretion, and metabolic production of cGMP during gestation in rats. , 1989, The American journal of physiology.

[34]  L. Ignarro,et al.  Biological Actions and Properties of Endothelium-Derived Nitric Oxide Formed and Released From Artery and Vein , 1989, Circulation research.

[35]  S. Moncada,et al.  The Discovery of Nitric Oxide as the Endogenous Nitrovasodilator , 1988, Hypertension.

[36]  S. Moncada,et al.  Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.

[37]  L. Ignarro,et al.  Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin. , 1981, The Journal of pharmacology and experimental therapeutics.

[38]  R. Furchgott,et al.  The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine , 1980, Nature.

[39]  J. Granger,et al.  Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. , 2000, Hypertension.

[40]  J. Granger,et al.  Differential expression of renal nitric oxide synthase isoforms during pregnancy in rats. , 1999, Hypertension.

[41]  Tamás Suto,et al.  IMPORTANCE OF NITRIC OXIDE IN CONTROL OF SYSTEMIC AND RENAL HEMODYNAMICS DURING NORMAL PREGNANCY STUDIES IN THE RAT AND IMPLICATIONS FOR PREECLAMPSIA , 1996 .

[42]  D. Kwiatkowski,et al.  Interleukin-6, tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia. , 1995, British journal of obstetrics and gynaecology.

[43]  Guy Hoffman,et al.  Estradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. , 1994, The Journal of clinical investigation.

[44]  M. Molnar,et al.  Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. , 1994, American journal of obstetrics and gynecology.

[45]  Krik P Conard.  Animal models of pre-eclampsia: do they exist? , 1990 .

[46]  D. Eder,et al.  A Role for Brain Angiotensin II in Experimental Pregnancy-Induced Hypertension in Laboratory Rats , 1987 .

[47]  L. Ignarro,et al.  The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. , 1985, Annual review of pharmacology and toxicology.